View Older Stories View More Recent Stories

Aug 22, 2024 09:20AM Positive 8-Week Body Weight Results from Lexaria's GLP-1 Diabetes Animal Study

Aug 21, 2024 09:17AM Lexaria Bioscience (LEXX): Positive Interim Blood Sugar Results From Lexaria's GLP-1 Diabetes Animal Study

Aug 21, 2024 09:00AM Positive Interim Blood Sugar Results from Lexaria's GLP-1 Diabetes Animal Study

Aug 19, 2024 09:08AM Lexaria Bioscience (LEXX) Announces Positive Results from Molecular Characterization Study

Aug 19, 2024 09:05AM Positive Results from Lexaria's Molecular Characterization Study

Jul 19, 2024 10:02AM H.C. Wainwright Reiterates Buy Rating on Lexaria Bioscience (LEXX)

Jul 17, 2024 10:33AM Lexaria Bioscience (LEXX) Reports Positive Interim Body Weight Results from Diabetes Animal Study

Jul 17, 2024 10:30AM Positive Interim Body Weight Results from Lexaria's Diabetes Animal Study

Jul 16, 2024 09:50AM Lexaria Bioscience (LEXX) Preparing For Strategic Growth

Jul 16, 2024 09:22AM Lexaria Bioscience (LEXX) Announces Plans for Growth

Jul 16, 2024 09:20AM Lexaria Preparing For Strategic Growth

Jul 10, 2024 06:43AM H.C. Wainwright Starts Lexaria Bioscience (LEXX) at Buy

Jul 9, 2024 09:10AM Dosing is Complete in Lexaria's Second GLP-1 Human Pilot Study

Jul 8, 2024 09:13AM Lexaria Bioscience (LEXX) Receives New Patents for Antiviral Drug Delivery and for Treating Epilepsy

Jul 8, 2024 09:10AM Lexaria Receives New Patents For Antiviral Drug Delivery and for Treating Epilepsy

Jun 18, 2024 09:00AM Lexaria Awards CRO Contract for 12-Week DehydraTECH GLP-1 Chronic Human Study

View More Recent Stories View Older Stories